CFFN CapFed notches modest Q1 2026 earnings beat but stock dips 077 percent in todays trading BIOA BioAge Labs posts narrower Q4 2025 loss than expected shares fall 11 percent today ADPT Adaptive Bio posts narrower than expected Q4 2025 loss shares rise 232 percent on investor optimism